Annexin Pharmaceuticals AB (publ) (STO:ANNX)
Sweden · Delayed Price · Currency is SEK 12.70
-0.55 (-4.15%)
Sep 4, 2026, 11:47 AM CET
STO:ANNX Market Cap
STO:ANNX has a market cap or net worth of 93.53 million as of September 3, 2026. Its market cap has decreased by -48.64% in one year.
Market Cap
93.53M
Enterprise Value
88.26M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
12.70
ChartMarket Cap Chart
Since April 19, 2017, STO:ANNX's market cap has increased from 50.21M to 93.53M, an increase of 86.28%. That is a compound annual growth rate of 6.86%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 3, 2026 | 93.53M | -33.08% |
| Dec 30, 2025 | 139.77M | -39.44% |
| Dec 30, 2024 | 230.78M | 161.10% |
| Dec 29, 2023 | 88.39M | -42.68% |
| Dec 30, 2022 | 154.19M | 12.35% |
| Dec 30, 2021 | 137.24M | 9.62% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 19, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Xintela AB | 142.11M |
| NextCell Pharma AB | 136.50M |
| Active Biotech AB | 134.97M |
| Simris Group AB (PUBL) | 134.17M |
| Biovica International AB | 131.36M |
| Nanologica AB | 123.95M |
| Spago Nanomedical AB | 89.82M |
| Ascelia Pharma AB | 84.26M |